These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 16286983)
1. Immunohistochemical localization of prostate-specific antigen in benign and malignant breast conditions. Nariţa D; Raica M; Anghel A; Suciu C; Cîmpean A Rom J Morphol Embryol; 2005; 46(1):41-5. PubMed ID: 16286983 [TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical detection of prostate specific antigen expression in human breast carcinoma cells. Bodey B; Bodey B; Kaiser HE Anticancer Res; 1997; 17(4A):2577-81. PubMed ID: 9252683 [TBL] [Abstract][Full Text] [Related]
3. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate. Sheridan T; Herawi M; Epstein JI; Illei PB Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of prostate-specific antigen does not correlate to other prognostic factors in breast cancer. Heyl W; Wolff JM; Biesterfeld S; Schröder W; Zitzelsberger D; Jakse G; Rath W Anticancer Res; 1999; 19(4A):2563-5. PubMed ID: 10470195 [TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical detection of prostate specific antigen expression in human primary and metastatic melanomas. Bodey B; Bodey B; Kaiser HE Anticancer Res; 1997; 17(3C):2343-6. PubMed ID: 9216712 [TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen value as a marker in breast cancer. Narita D; Cimpean AM; Anghel A; Raica M Neoplasma; 2006; 53(2):161-7. PubMed ID: 16575473 [TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical detection of prostate-specific antigen (PSA) in skin adnexal and breast tissues and tumors. Papotti M; Paties C; Peveri V; Moscuzza L; Bussolati G Basic Appl Histochem; 1989; 33(1):25-9. PubMed ID: 2471501 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical localization of transferrin in human breast cancer tissue. Agarwal PK; Mehrotra A; Chandra T; Singh K Indian J Pathol Microbiol; 2001 Apr; 44(2):107-11. PubMed ID: 11883122 [TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors. Monne M; Croce CM; Yu H; Diamandis EP Cancer Res; 1994 Dec; 54(24):6344-7. PubMed ID: 7527295 [TBL] [Abstract][Full Text] [Related]
11. Significance of micrometastases in pelvic lymph nodes detected by real-time reverse transcriptase polymerase chain reaction in patients with clinically localized prostate cancer undergoing radical prostatectomy after neoadjuvant hormonal therapy. Miyake H; Kurahashi T; Hara I; Takenaka A; Fujisawa M BJU Int; 2007 Feb; 99(2):315-20. PubMed ID: 17155986 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical labelling for prostate specific antigen in non-prostatic tissues. Alanen KA; Kuopio T; Koskinen PJ; Nevalainen TJ Pathol Res Pract; 1996 Mar; 192(3):233-7. PubMed ID: 8739470 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical localization of prostate-specific antigen in benign and malignant breast tissues. Howarth DJ; Aronson IB; Diamandis EP Br J Cancer; 1997; 75(11):1646-51. PubMed ID: 9184181 [TBL] [Abstract][Full Text] [Related]
14. [Determination of prostate-specific antigen (PSA) in cytosol of breast tumors and human endometrium--new diagnostic approaches]. Seliger E; Kaltwasser P; Röpke F Zentralbl Gynakol; 1998; 120(4):172-5. PubMed ID: 9610520 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of prostate-specific antigen in female breast cancer. Ilvan S; Celik V; Cetinaslan I; Calay Z; Ferahman M J BUON; 2004; 9(2):183-6. PubMed ID: 17415812 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of prostate specific antigen (PSA) in benign and malignant tumors of the prostate. Dema A; Tudose N Rom J Morphol Embryol; 1998; 44(1-4):93-100. PubMed ID: 15678849 [TBL] [Abstract][Full Text] [Related]
17. Correlation of prostate specific antigen immunoactivity (IR-PSA) to other prognostic factors in female breast cancer. Griniatsos J; Diamantis E; Gioti J; Karyda I; Vassilopoulos PP; Agnanti N Anticancer Res; 1998; 18(1B):683-8. PubMed ID: 9584052 [TBL] [Abstract][Full Text] [Related]
18. Higher expression of the androgen-regulated gene PSA/HK3 mRNA in prostate cancer tissues predicts biochemical recurrence-free survival. Sterbis JR; Gao C; Furusato B; Chen Y; Shaheduzzaman S; Ravindranath L; Osborn DJ; Rosner IL; Dobi A; McLeod DG; Sesterhenn IA; Srivastava S; Cullen J; Petrovics G Clin Cancer Res; 2008 Feb; 14(3):758-63. PubMed ID: 18245536 [TBL] [Abstract][Full Text] [Related]
19. Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): a clinically useful predictor for axillary lymph node metastases. Braun M; Flucke U; Debald M; Walgenbach-Bruenagel G; Walgenbach KJ; Höller T; Pölcher M; Wolfgarten M; Sauerwald A; Keyver-Paik M; Kühr M; Büttner R; Kuhn W Breast Cancer Res Treat; 2008 Dec; 112(3):503-11. PubMed ID: 18165897 [TBL] [Abstract][Full Text] [Related]
20. Prostate specific antigen--new applications in breast and other cancers. Diamandis EP Anticancer Res; 1996; 16(6C):3983-4. PubMed ID: 9042323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]